What Bacteria Cause Sinus Infections and How to Treat Them

Most sinus infections are viral, not bacterial. Learn which bacteria are actually responsible and when antibiotics are the right call.

Most bacterial sinus infections are caused by a handful of species that normally live in or near the nose and throat. In acute cases, the usual culprits are Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, though the mix shifts depending on whether the infection is short-lived, chronic, or linked to a dental problem. Treatment typically starts with amoxicillin-clavulanate, but the right approach depends on the likely bacteria involved, how long you’ve been sick, and whether you’ve taken antibiotics recently.

The Bacteria Behind Acute Sinus Infections

When doctors talk about acute bacterial rhinosinusitis, they mean a sinus infection that has lasted at least ten days or that suddenly worsened after an initial improvement from a cold. A large meta-analysis examining bacterial cultures from acute sinusitis patients found that the five most common bacteria were methicillin-susceptible Staphylococcus aureus (about 21% of cases), coagulase-negative staphylococci (about 17%), Streptococcus pneumoniae (about 16%), viridans group streptococci (about 13%), and Haemophilus influenzae (about 12%). That ranking may surprise you if you’ve read older textbooks, which tended to list S. pneumoniae as the top pathogen. The picture has shifted over the past two decades, partly because of widespread pneumococcal vaccination in children and partly because of improved culture techniques that catch staphylococci more reliably.

Haemophilus influenzae, specifically the non-typeable strains that lack a capsule, remains a major player in mucosal infections including sinusitis, otitis media, and conjunctivitis. In children, Moraxella catarrhalis rounds out the classic trio of pediatric sinus pathogens. It colonizes the noses of young kids at remarkably high rates and produces enzymes that break down certain antibiotics, which matters when choosing treatment.

An important wrinkle: most sinus infections that feel bacterial are actually viral. Colds cause sinus congestion, facial pressure, and discolored mucus all on their own. In a study of children with sinus symptoms, about one in five had completely normal sinus imaging, suggesting a viral cause rather than a bacterial one. Green or yellow mucus alone doesn’t prove bacteria are involved. The clinical signs that point more strongly toward a bacterial infection include symptoms lasting beyond ten days without improvement, a pattern of getting better and then sharply worsening, or high fever with purulent drainage persisting for several days straight.

How the Bacteria Differ in Chronic Sinusitis

Chronic rhinosinusitis, defined as symptoms persisting for twelve weeks or more, involves a different bacterial landscape. Staphylococcus aureus takes on a larger role, particularly in patients who have nasal polyps. The bacterium is associated with persistent, severe inflammation of the upper airway and is linked to worse outcomes in people who also have allergic rhinitis or atopic dermatitis. Methicillin-resistant strains, or MRSA, are increasingly being identified in sinusitis cases as well, which complicates antibiotic choices considerably.

Chronic infections also tend to involve a broader mix of organisms. Pseudomonas aeruginosa shows up more often in patients who have had prior sinus surgery or who use nasal rinses with contaminated water. Anaerobic bacteria, which thrive in low-oxygen environments, become more relevant as sinuses stay blocked for extended periods. The shift from a single dominant pathogen to a community of bacteria is one reason chronic sinusitis responds poorly to the standard short courses of antibiotics that work fine for acute infections.

When a Dental Problem Seeds the Sinuses

Between 10% and 40% of maxillary sinus infections originate from a dental source, and these odontogenic infections harbor a completely different set of bacteria. The roots of the upper back teeth sit very close to the floor of the maxillary sinus, sometimes separated by less than a millimeter of bone. An infected tooth root, a failed root canal, or a dental implant complication can push bacteria directly into the sinus cavity.

The bacteria in odontogenic sinusitis are predominantly anaerobic and the infections tend to be polymicrobial, meaning multiple species are involved at once. The most common isolates include Prevotella, Fusobacterium, and Peptostreptococcus species. More recent molecular analysis using quantitative PCR has confirmed this picture, finding Porphyromonas gingivalis in nearly all periapical lesion specimens, along with Fusobacterium species and the Streptococcus anginosus group, all of which can migrate from the tooth root into the sinus.

This matters for treatment because standard sinusitis antibiotics are chosen to cover the usual aerobic suspects. If the infection actually started from a tooth, those antibiotics may miss the anaerobes driving the problem. Odontogenic sinusitis is typically unilateral, affecting one side only, and often has an unusually foul smell. If your doctor suspects a dental origin, treatment usually requires addressing the dental problem itself alongside antibiotics that cover anaerobic bacteria, and the microbiology of the infection is distinctly different from non-dental cases.

Biofilms and Why Some Infections Keep Coming Back

One of the most frustrating aspects of chronic sinusitis is its tendency to recur, even after what seems like adequate antibiotic treatment. Bacterial biofilms are a major reason. A biofilm is a structured community of bacteria encased in a self-produced matrix of sugars and proteins that sticks to the sinus lining. Inside this matrix, bacteria are shielded from both antibiotics and your immune system’s attack cells.

The presence of biofilms has been strongly implicated in chronic rhinosinusitis, helping explain why antibiotics fail, symptoms drag on, and infections bounce back after treatment stops. Research has connected biofilm formation to greater symptom severity and worse clinical indicators in chronic sinusitis patients. Staphylococcus aureus and Pseudomonas aeruginosa are particularly effective biofilm builders in the sinuses.

This is why chronic sinusitis treatment often involves strategies beyond antibiotics alone. High-volume saline rinses can physically disturb biofilms. Sinus surgery opens blocked drainage pathways and removes polyps where biofilms tend to anchor. And some newer approaches, discussed later in this article, aim to kill biofilm bacteria specifically.

First-Line Antibiotic Treatment

For a straightforward acute bacterial sinus infection in someone who hasn’t taken antibiotics recently, amoxicillin-clavulanate is the standard first choice. The clavulanate component disables the beta-lactamase enzymes that bacteria like H. influenzae and M. catarrhalis produce to chew up penicillin-type drugs. Treatment guidelines rank amoxicillin-clavulanate alongside respiratory fluoroquinolones and ceftriaxone as the antibiotics with the highest predicted success rates, in the range of 90% or above for adults.

For adults with mild disease who haven’t been on antibiotics in the past month or so, amoxicillin-clavulanate at standard or high doses is generally the recommended initial therapy. If you’ve recently completed a course of antibiotics or your infection is more than mildly severe, guidelines suggest starting with either high-dose amoxicillin-clavulanate or a respiratory fluoroquinolone such as levofloxacin or moxifloxacin. The logic is that recent antibiotic use increases your chances of harboring resistant organisms, so you need to start with something stronger.

For children, high-dose amoxicillin-clavulanate is typically first-line regardless of severity, because fluoroquinolones carry more concerns in growing bodies. A typical course runs 10 to 14 days for adults, though some guidelines allow 5 to 7 days for uncomplicated cases. Children generally receive the full 10-to-14-day course.

Options for Penicillin Allergies and Resistant Infections

If you’re allergic to penicillin, the backup options depend on how severe the allergy is. For mild penicillin allergies (a rash but no breathing problems), certain cephalosporins such as cefuroxime, cefpodoxime, or cefdinir may be used, since the cross-reactivity risk with these newer cephalosporins is low. For more serious penicillin allergies involving anaphylaxis or swelling, macrolides like azithromycin or clarithromycin are sometimes prescribed, though rising resistance among S. pneumoniae strains makes them less reliable than they once were. Trimethoprim-sulfamethoxazole is another alternative that some guidelines recommend for penicillin-allergic patients.

Antibiotic resistance in sinus infections is a real and growing concern. An analysis of pneumococcal sinusitis in United States adults estimated that roughly 19% of cases involved strains resistant to three or more antibiotic classes, and about 10% were resistant to at least one first-line outpatient antibiotic. For H. influenzae, the main resistance mechanism is beta-lactamase production, which is exactly what the clavulanate in amoxicillin-clavulanate is designed to overcome. This is one reason plain amoxicillin without clavulanate has fallen out of favor as a first-line choice in many guidelines.

Saline Rinses and Nasal Steroids

Antibiotics address the bacteria, but several non-antibiotic treatments help manage symptoms and may speed recovery. Saline nasal irrigation is one of the best-studied and most universally recommended add-ons. High-volume rinses using a squeeze bottle or neti pot flush out mucus, bacteria, and inflammatory debris from the sinus cavities. For acute infections, saline rinses are a useful supplement. For chronic sinusitis, especially after sinus surgery, they become a cornerstone of long-term management.

Adding a corticosteroid like budesonide to the saline rinse appears to work even better than saline alone for post-surgical patients. A meta-analysis found that steroid nasal irrigation after sinus surgery led to statistically significant improvements in symptom scores and endoscopic appearance compared to saline-only rinses, with benefits evident at two weeks, six weeks, and twelve weeks of follow-up. Intranasal corticosteroid sprays (fluticasone, mometasone, and similar drugs) are also commonly used for both acute and chronic sinusitis to reduce mucosal swelling and improve sinus drainage.

How Doctors Identify the Bacteria

In most acute sinus infections, your doctor won’t take a culture. Treatment is empiric, meaning the antibiotic is chosen based on which bacteria are most likely responsible given your symptoms, location, and history. Cultures become more important when infections don’t respond to initial treatment, recur frequently, or when the patient has had prior sinus surgery.

The gold standard for identifying sinus bacteria has traditionally been maxillary sinus puncture, where a needle is inserted through the wall of the sinus to aspirate fluid directly. It’s accurate but uncomfortable, so a less invasive alternative has become widely used: endoscopically guided middle meatal cultures. In this approach, an endoscope is used to place a swab in the middle meatus, the drainage corridor of the maxillary sinus. Early studies found this method matched aspirate cultures in identifying the dominant pathogen more than 90% of the time.

A systematic review and meta-analysis later confirmed that middle meatal cultures show a significant correlation with maxillary sinus puncture results, with fair overall diagnostic accuracy. Accuracy was highest in children and in chronic cases, and when samples were collected via suction rather than a simple swab. For chronic sinusitis, culture-directed antibiotic therapy, where treatment is guided by what actually grows in the lab, is often recommended as a central part of management.

When Sinus Infections Become Dangerous

The vast majority of bacterial sinus infections resolve with appropriate treatment or even on their own. But in rare cases, infection can spread beyond the sinus walls into neighboring structures, and the results can be devastating. The sinuses are separated from the brain by thin plates of bone, and the frontal and sphenoid sinuses in particular sit dangerously close to the cranial cavity.

Complications include orbital cellulitis (infection spreading to the eye socket), subdural empyema (a pus collection between the brain’s membranes), and intracranial abscesses. A case report described a previously healthy 14-year-old girl whose sinus infection evolved into a frontal subdural empyema with bone erosion, eventually progressing to brain herniation and a fatal outcome complicated by jugular vein thrombosis and septic emboli to the lungs. Another case involved a 12-year-old who presented with fever, cough, and severely diminished consciousness secondary to a subdural empyema from contiguous spread of acute bacterial sinusitis.

These cases are extremely uncommon, but they underscore why worsening headache, high fever, visual changes, or altered mental status during a sinus infection warrant immediate medical attention. Adolescents and young adults seem to be at slightly higher risk for intracranial complications from frontal sinusitis, possibly because the vascular connections between the frontal sinus and the brain are more active during growth.

Invasive fungal sinusitis is another rare but life-threatening condition, especially in people with diabetes or weakened immune systems. A case-control study comparing invasive fungal sinusitis with bacterial sinusitis found that diabetes was the most important risk factor for the fungal form, and the mortality rate in the fungal group was far higher than in bacterial sinusitis patients. Warning signs include visual loss, double vision, and black crusting inside the nose.

The Sinus Microbiome and Microbial Diversity

Researchers are increasingly looking at sinus infections not just as “one bad bug invades” but as a breakdown in the complex community of microorganisms that normally inhabit the sinuses. Healthy sinuses aren’t sterile. They contain diverse bacterial populations that coexist and, in some ways, keep each other in check. A growing body of evidence suggests that greater microbial diversity in the sinuses may actually be protective against chronic sinusitis, and patients with better diversity may respond more favorably to treatment.

Studies comparing the sinus microbiome of chronic sinusitis patients to healthy controls have found significantly lower bacterial diversity in the sinusitis group, whether or not nasal polyps are present. Whether this loss of diversity causes chronic sinusitis or results from it is still unclear, but the pattern is consistent enough that it has shifted how some researchers think about the disease. The implication is that aggressive, repeated antibiotic use might actually worsen the problem for some chronic sinusitis patients by further depleting microbial diversity, even if it kills the immediate pathogen.

Bacteriophage Therapy for Stubborn Infections

When standard antibiotics, sinus surgery, and steroid rinses all fail to clear a chronic sinus infection, the options get thin. One of the more promising experimental approaches is bacteriophage therapy, which uses viruses that specifically target and destroy bacteria. Phages are naturally occurring and highly specific: a phage that kills S. aureus won’t harm other bacteria or human cells.

Early clinical work has shown encouraging signs. In a small trial of nine patients with chronic S. aureus sinus infections, topical application of bacteriophages reduced bacterial growth in all patients, and two achieved negative cultures after treatment. Long-term safety studies in animal models have shown that phage cocktails applied to the frontal sinus region appear safe for extended use and can effectively target a wide range of S. aureus clinical isolates from chronic sinusitis patients.

Phage therapy is not yet available as a standard treatment and faces real hurdles, including regulatory approval, the need to match specific phages to the patient’s specific bacterial strain, and the possibility that bacteria can develop phage resistance just as they do with antibiotics. But for the subset of chronic sinusitis patients whose infections are driven by biofilm-forming, antibiotic-resistant S. aureus or Pseudomonas, phages represent one of the few genuinely new ideas in a field that has been recycling the same antibiotic strategies for decades.

Anatomical Factors and Sinus Infection Risk

Many people with recurrent sinus infections wonder whether their anatomy is to blame. A deviated septum and concha bullosa (an air-filled enlargement of the middle turbinate bone) are the two structural variations most commonly blamed for chronic sinus problems. The evidence supporting these connections is weaker than most people expect. A retrospective imaging study found no significant association between nasal septal deviation and maxillary sinusitis, and no significant link between concha bullosa and sinusitis prevalence either. Another study suggested that concha bullosa may predispose to sinusitis, but the strength of that relationship remains debated.

The factors with stronger evidence for increasing sinus infection risk include allergies (which cause chronic mucosal swelling that blocks drainage), smoking, immune system problems, cystic fibrosis, and conditions like ciliary dyskinesia where the tiny hairs that sweep mucus out of the sinuses don’t work properly. If you have frequent sinus infections and an ENT has mentioned a deviated septum on imaging, it’s worth discussing, but the septum alone probably isn’t the full explanation. Addressing underlying allergies, avoiding cigarette smoke, and managing conditions like acid reflux that irritate the nasal lining tend to make a larger practical difference for most people.